P25440 (BRD2_HUMAN) Homo sapiens (Human)

Bromodomain-containing protein 2 UniProtKBInterProSTRINGInteractive Modelling

801 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 2 identical sequences: Homo sapiens: A0A024RCR5; Gorilla gorilla gorilla: A0A2I2YDK8

Available Structures

121 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Crystal structure analysis of the N-terminal bromodomain of human BRD2 complexed with acetylated hi… Heteromer
P02309;
73-186
Assess
Crystal structure analysis of the N-terminal bromodomain of human BRD2 complexed with acetylated hi… Heteromer
P02309;
73-186
Assess
Solution structures of Brd2 second bromodomain in complex with stat3 peptide Heteromer
P40763;
344-455
Assess
Crystal structure of the human Brd2 second bromodomain in complexed with the acetylated histone H4 … Heteromer
P02309;
348-455
Assess
N-Terminal Bromodomain of Human BRD2 With IBET-151homo-2-merACT;GOL;1GH;72-189
Assess
Crystal Structure of the human BRD2 BD1 bromodomain in complex with a Tetrahydroquinoline analoguehomo-2-merG7V;SO4;EDO;03S;73-187
Assess
N-Terminal bromodomain of Human BRD2 with a Tetrahydroquinoline analoguehomo-2-merSO4;G3J;EPE;72-186
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5 ethyl-3-methyl-4-phenyl-1, 2-oxazolehomo-2-merEDO;A9O;SO4;74-188
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopropyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylb…homo-2-merEDO;A9N;SO4;72-186
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-methyl-1,2,3,4- tetrahydroquinazolin-2-onehomo-2-merP9I;SO4;EDO;72-186
Assess
Crystal structure analysis of the N-terminal bromodomain of human Brd2homo-2-merDTT;73-186
Assess
N-Terminal Bromodomain of Human BRD2 With tbutyl-phenyl-amino- dimethyl-oxazolyl-quinoline-carboxyl…homo-2-merEDO;S5B;SO4;73-186
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-methyl-1,2,3,4- tetrahydroquinazolin-2-onehomo-2-mer3PF;EDO;SO4;73-186
Assess
Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GSK525762 (IBET)homo-2-merEAM;74-187
Assess
BRD2_Bromodomain1 complex with inhibitor 744homo-2-merEDO;HWV;73-186
Assess
Crystal structure analysis of the N-terminal bromodomain of human BRD2 complexed with acetylated hi…homo-2-mer73-186
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopentyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylb…homo-2-merP9M;SO4;73-186
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5-(4-(4-fluorophenyl)-1H-imidazol-5-yl)-1-methylpyridin-2…homo-2-merSO4;NUQ;EDO;73-186
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1H-benzo[d]i…homo-2-merSO4;NUH;EDO;73-185
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-(2-methyl-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-onehomo-2-merEDO;TVP;SO4;75-186
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-METHYLPYRROLIDIN-2-ONEhomo-2-merMB3;SO4;EDO;75-185
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3,5 dimethyl-4-phenyl-1,2- oxazolehomo-2-merEDO;A9P;SO4;75-183
Assess
Crystal structure of BRD2(BD2) mutant W370F in the free formhomo-2-merNI;2PE;GOL;347-454
Assess
Discovery and the crystal structure of NS5 in complex with the N-terminal bromodomain of BRD2.homo-2-merBUX;SO4;DTT;GOL;DMS;PGE;75-182
Assess
Crystal structure of BRD2(BD1)with ligand BY27 boundhomo-2-merCQF;MES;76-183
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4-hydroxyphenyl) acetamidehomo-2-merEDO;TYL;SO4;77-182
Assess
Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GW841819Xhomo-2-merWSH;SO4;77-181
Assess
BRD2-BD2 in complex with the cyclic peptide 4.2_3homo-2-mer351-454
Assess
Solution structure of the Extraterminal (ET) Domain of BRD2monomer621-750
Assess
BRD2-BD1 in complex with the cyclic peptide 3.2_2monomerIOD;GOL;NH2;PE3;65-190
Assess
BRD2-BD1 in complex with the cyclic peptide 4.2_3monomer65-190
Assess
Crystal structure of the N-terminus D161Y bromodomain mutant of human BRD2monomerEDO;ACT;71-190
Assess
N-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A)monomerEDO;73B;SO4;71-189
Assess
BRD2-BD1 in complex with the cyclic peptide 3.1_3monomerZN;70-187
Assess
Crystal structure of the N-terminus Y153H bromodomain mutant of human BRD2monomerEDO;71-187
Assess
N-terminal bromodomain of human BRD2 in complex with 4,4'-(quinoline-5,7-diyl)bis(3,5-dimethylisoxa…monomerJWD;74-187
Assess
N-terminal bromodomain of human BRD2 in complex with N-cyclopentyl-7-(3,5-dimethylisoxazol-4-yl)qui…monomerJVY;74-187
Assess
N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methy…monomerJWA;74-187
Assess
Crystal structure of the human BRD2 BD1 bromodomain in complex with a BRD2-interactive compound, BI…monomerBYH;MES;73-186
Assess
X-ray crystal structure of bromodomain 2 of human brd2 in complex with rvx208 to 1.08 A resolutionmonomer1K0;EDO;344-455
Assess
Human Brd2(BD2) mutant in free formmonomer9JB;CL;DQW;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH (R)-N5-cyclopropyl-N3-methyl-2-oxo-1-(1-phenylethyl)-1,2-…monomerEDO;ULH;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH oxabicyclo(hexan-6-yl)-N2-methyl-6-((S)-1-phenylethyl)pyr…monomerEDO;PE4;ULN;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N5-((1R,5S,6r)-3-oxabicyclo[3.1.0]hexan-6-yl)-3-(1H-indol…monomerEDO;V9Q;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1,5-dimethyl-N-(2-(methylamino)-2-oxo-1-(tetrahydro-2H-py…monomer80Z;EDO;PE4;344-455
Assess
Crystal structure of BRD2(BD2) mutant in free formmonomerACT;GOL;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK973monomerEDO;1PG;QC8;344-455
Assess
Human BRD2 C-terminal bromodomain with (S)-1-(2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-6-(1,2,3,6-…monomerEDO;D7B;PEG;MES;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK620monomerEDO;QCZ;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-(2-(benzyloxy)phenyl)-5-methyl-1H-1,2,4-triazolemonomerEDO;PE4;ULB;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 6-((S)-hydroxy(phenyl)methyl)-N2-methyl-N4-((1S,2S)-2-met…monomerEDO;ULK;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1,5-dimethyl-N-(2-(methylamino)-2-oxoethyl)-6-oxo-N-(2-ph…monomerEDO;PE4;VBE;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N4-((1R,5S,6r)-3-oxabicyclo[3.1.0]hexan-6-yl)-6-((S)-meth…monomerEDO;ULQ;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH iBET-BD2 (GSK046)monomerEDO;LW5;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(2-(1H-imidazol-4-yl)ethyl)-4-acetamido-3-(benzyloxy)be…monomerPEG;EDO;QB5;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-benzyl-N-methyl-2-oxo-1,2-dihydropyridine-3-carboxamidemonomerEDO;QCW;MES;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-methyl-4-propionyl-1H-pyrrole-2-carboxamidemonomerEDO;PE4;V9B;344-455
Assess
Human BRD2 C-terminal bromodomain with (S)-5-(1-acetyl-2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-1,…monomerEDO;MES;D7H;344-455
Assess
Crystal structure of BRD2(BD2) mutant with ligand ET bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)…monomerGOL;2PE;31P;NI;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH (S)-N-ethyl-3-(1-methyl-1H-1,2,3-triazol-4-yl)-4-(1-pheny…monomerEDO;UL8;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-ethyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)-6-(1-phenyleth…monomerUME;EDO;PEG;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH (S)-N4-cyclopropyl-N2-methyl-6-(1-phenylethyl)pyridine-2,…monomerULE;EDO;344-455
Assess
Human Brd2(BD2) mutant in complex with MEmonomer31O;CL;DQW;344-455
Assess
Human BRD2 C-terminal bromodomain with 2-((4-acetyl-3-cyclopropyl-3,4-dihydroquinoxalin-1(2H)-yl)me…monomerPEG;EDO;D7Q;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1H-benzo[d]i…monomerEDO;PE4;NV2;344-455
Assess
Crystal structure of the second bromodomain (BD2) of human BRD2 bound to LRRK2-IN-1monomerBU1;4K4;344-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK549monomerEDO;QD5;PEG;344-455
Assess
Human Brd2(BD2) mutant in complex with AL-tBumonomer9HN;CL;DQW;344-454
Assess
X-ray crystal structure of human BRD2(BD2) in complex with RVX297 to 1.55 A resolutionmonomer5GD;345-455
Assess
Human Brd2(BD2) mutant in complex with 9-Memonomer9J2;CL;DQW;345-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 6-benzyl-N2-methyl-N4-((1S,2S)-2-methylcyclopropyl)pyridi…monomerUL5;EDO;345-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-ethyl-3-(1-methyl-1H-1,2,3-triazol-4-yl)-4-(pyridin-2-y…monomerEDO;UM5;345-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-benzyl-N5-cyclopropyl-N3-methyl-1H-pyrazole-3,5-dicarbo…monomerEDO;VE5;PEG;345-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 2-benzyl-N-cyclopropyl-6-(1-methyl-1H-1,2,3-triazol-4-yl)…monomerUM8;EDO;345-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N4-hydroxycyclohexyl-N2-methyl-5-phenylethyl-furan-2,4-di…monomerV9K;EDO;345-455
Assess
Crystal structure of BRD2 second bromodomain in complex with SGC-CBP30 chemical probemonomerEDO;2LO;346-455
Assess
Crystal structure of the second bromodomain (BD2) of human BRD2 bound to bromosporinemonomerBMF;EDO;SO4;346-455
Assess
Human Brd2(BD2) L383V mutant in complex with ET-JQ1-OMemonomerPMW;PXN;345-454
Assess
Human Brd2(BD2) mutant in complex with 9-ETmonomer9J5;CL;DQW;345-454
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH iBET-BD1 (GSK778)monomerLWB;EDO;346-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 2-benzyl-N-cyclopropyl-6-(1-methyl-1H-1,2,3-triazol-4-yl)…monomerUMB;EDO;346-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(2,2-diphenylethyl)-1,5-dimethyl-N-(2-(methylamino)-2-o…monomerVBH;EDO;346-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N5-hydroxycyclohexyl-N3-methyl-1-phenylethyl-1H-pyrazole-…monomerV9H;EDO;346-455
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH rac-N5-((1R,5S)-3-oxabicyclo[3.1.0]hexan-6-yl)-N7,3-dimet…monomerV9N;EDO;346-455
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor JQ1monomerJQ1;NI;EDO;346-455
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (R…monomerEDO;DMS;1K0;346-455
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (R…monomerEDO;DMS;1K0;346-455
Assess
Human Brd2(BD2) mutant in complex with ET-Am1monomer9HT;CL;DQW;346-455
Assess
Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)…monomer31O;2PE;NI;GOL;346-455
Assess
Human Brd2(BD2) mutant in complex with AL-Am1monomer9J8;346-455
Assess
Crystal structure of the second bromodomain (BD2) of human BRD2 bound to Ro3280monomer79C;CL;346-455
Assess
C-terminal bromodomain of human BRD2 in complex with 4-(2-cyclopropyl-7-(6-methylquinolin-5-yl)-1H-…monomerJW4;GOL;346-454
Assess
Human Brd2(BD2) mutant in complex with Me-Am1monomer9HW;CL;DQW;346-454
Assess
Human Brd2(BD2) mutant in complex with 9-ME-Am1monomer9HQ;CL;DQW;346-454
Assess
Crystal structure of the second bromodomain Q443H mutant of human BRD2monomer346-454
Assess
BRD2-BD2 in complex with the cyclic peptide 3.1_3monomer347-455
Assess
Crystal structure of BRD2(BD2) W370F mutant with ligand I-BET 762 boundmonomerGOL;2PE;EAM;NI;346-454
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-((2R,4S)-2-methyl-4-(phenylamino)-6-(4-(piperidin-1-ylm…monomer9S3;75-183
Assess
BRD2-BD2 in complex with a diacetylated-H2A.Z peptidemonomer347-455
Assess
X-ray crystal structure of 1,2,3-triazolobenzodiazepine in complex with BRD2(D2)monomer7WY;EDO;347-455
Assess
Crystal structure of the N-terminus R100L bromodomain mutant of human BRD2monomerEDO;75-183
Assess
Crystal structure of the second bromodomain of human BRD2 in complex with a tetrahydroquinoline ana…monomerSO4;EDO;8J2;346-454
Assess
C-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A)monomer73B;SO4;347-455
Assess
Ultra high resolution crystal structure of the apo- form of second bromodomain of BRD2.monomerCL;GOL;PGE;348-455
Assess
Crystal Structure of the human BRD2 BD2 bromodimain in complex with a Tetrahydroquinoline analoguemonomerG7V;EDO;348-455
Assess
Second bromodomain of Human BRD2 with a Tetrahydroquinoline analoguemonomerEDO;G3J;348-455
Assess
Crystal Structure of the second bromodomain of BRD2 in complex with RT53monomerH7B;EDO;348-455
Assess
Crystal structure of BRD2(BD2)with ligand BY27 boundmonomerCQF;347-454
Assess
Crystal structure of the BRD2-BD2 in complex with phenanthridinonemonomerGOL;2ME;LDR;348-455
Assess
Crystal structure analysis of the second bromodomain of BRD2 covalently linked to b-mercaptoethanolmonomerPGE;GOL;348-455
Assess
Crystal structure of BRD2(BD2) W370F mutant with ligand 28 boundmonomer59E;GOL;347-454
Assess
Crystal Structure of the second bromodomain of BRD2 in complex with RT56monomerMES;EDO;H7E;348-455
Assess
Crystal structure of the second bromodomain of the human Brd2 proteinmonomerEPE;348-455
Assess
BRD2 Bromodomain2 with A-1360579monomer87D;347-454
Assess
Human Brd2(BD2) mutant in complex with ALmonomer9HZ;347-454
Assess
Human Brd2(BD2) mutant in complex with ETmonomer31P;347-454
Assess
Solution structure of a Bromodomain from RING3 proteinmonomer348-455
Assess
Ultra-high resolution crystal structure of second bromodomain of BRD2 in complex with inhibitor 6B3monomerCL;GOL;6B3;348-454
Assess
BRD2_Bromodomain2 complex with pyrrolopyridone compound 27monomerQYY;348-454
Assess
Crystal structure of the second bromodomain of human BRD2 in complex with a tetrahydroquinoline inh…monomer5P4;348-454
Assess
BRD2_Bromodomain2 complex with inhibitor 744monomerHWV;348-454
Assess

2 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer73B;0.844uyg.1.A347-455
100.00
Assess
monomer0.816dne.1.A61-183
64.03
Assess

5 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomer73B;0.844uyg.1.A347-455
100.00
Assess
Isoform 2monomer0.806dne.1.A61-183
64.29
Assess
Isoform 3monomer73B;0.844uyg.1.A300-408
100.00
Assess
Isoform 3monomer0.816dne.1.A14-136
64.29
Assess
Isoform 4monomer73B;0.844uyg.1.A227-335
100.00
Assess

Alignments